Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study.

Broger T, Sossen B, du Toit E, Kerkhoff AD, Schutz C, Ivanova Reipold E, Ward A, Barr DA, Macé A, Trollip A, Burton R, Ongarello S, Pinter A, Lowary TL, Boehme C, Nicol MP, Meintjes G, Denkinger CM.

Lancet Infect Dis. 2019 May 30. pii: S1473-3099(19)30001-5. doi: 10.1016/S1473-3099(19)30001-5. [Epub ahead of print]

2.

Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation.

Colman RE, Mace A, Seifert M, Hetzel J, Mshaiel H, Suresh A, Lemmer D, Engelthaler DM, Catanzaro DG, Young AG, Denkinger CM, Rodwell TC.

PLoS Med. 2019 Apr 30;16(4):e1002794. doi: 10.1371/journal.pmed.1002794. eCollection 2019 Apr. Erratum in: PLoS Med. 2019 Jun 3;16(6):e1002823.

3.

Addressing critical needs in the fight to end tuberculosis with innovative tools and strategies.

Hatherill M, Chaisson RE, Denkinger CM.

PLoS Med. 2019 Apr 30;16(4):e1002795. doi: 10.1371/journal.pmed.1002795. eCollection 2019 Apr.

4.

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients.

Broger T, Tsionksy M, Mathew A, Lowary TL, Pinter A, Plisova T, Bartlett D, Barbero S, Denkinger CM, Moreau E, Katsuragi K, Kawasaki M, Nahid P, Sigal GB.

PLoS One. 2019 Apr 18;14(4):e0215443. doi: 10.1371/journal.pone.0215443. eCollection 2019.

5.

Author Correction: A systematic review of biomarkers to detect active tuberculosis.

MacLean E, Broger T, Yerlikaya S, Fernandez-Carballo BL, Pai M, Denkinger CM.

Nat Microbiol. 2019 May;4(5):899. doi: 10.1038/s41564-019-0452-3.

PMID:
30976122
6.

Diagnostic Accuracy of Stool Xpert MTB/RIF for Detection of Pulmonary Tuberculosis in Children: a Systematic Review and Meta-analysis.

MacLean E, Sulis G, Denkinger CM, Johnston JC, Pai M, Ahmad Khan F.

J Clin Microbiol. 2019 May 24;57(6). pii: e02057-18. doi: 10.1128/JCM.02057-18. Print 2019 Jun.

7.

Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India.

Sarin S, Huddart S, Raizada N, Parija D, Kalra A, Rao R, Salhotra VS, Khaparde SD, Boehme C, Denkinger CM, Sohn H.

PLoS One. 2019 Apr 1;14(4):e0214675. doi: 10.1371/journal.pone.0214675. eCollection 2019.

8.

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF.

Ponnudurai N, Denkinger CM, Van Gemert W, Pai M.

J Epidemiol Glob Health. 2018 Dec;8(3-4):103-105. doi: 10.2991/j.jegh.2018.04.005. No abstract available.

PMID:
30864749
9.

A systematic review of biomarkers to detect active tuberculosis.

MacLean E, Broger T, Yerlikaya S, Fernandez-Carballo BL, Pai M, Denkinger CM.

Nat Microbiol. 2019 May;4(5):748-758. doi: 10.1038/s41564-019-0380-2. Epub 2019 Feb 25. Erratum in: Nat Microbiol. 2019 Apr 11;:.

PMID:
30804546
10.

Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset.

Freiman JM, Wang J, Easterbrook PJ, Horsburgh CR, Marinucci F, White LF, Kamkamidze G, Krajden M, Loarec A, Njouom R, Nguyen KV, Shiha G, Soliman R, Solomon SS, Tsertsvadze T, Denkinger CM, Linas B.

J Hepatol. 2019 Jul;71(1):62-70. doi: 10.1016/j.jhep.2019.02.011. Epub 2019 Feb 21.

PMID:
30797050
11.

The impact of Xpert MTB/RIF-do we have a final answer?

Schumacher SG, Denkinger CM.

Lancet Glob Health. 2019 Feb;7(2):e161-e162. doi: 10.1016/S2214-109X(18)30493-5. No abstract available.

12.

Toward the Development of a Circulating Free DNA-Based In Vitro Diagnostic Test for Infectious Diseases: a Review of Evidence for Tuberculosis.

Fernández-Carballo BL, Broger T, Wyss R, Banaei N, Denkinger CM.

J Clin Microbiol. 2019 Mar 28;57(4). pii: e01234-18. doi: 10.1128/JCM.01234-18. Print 2019 Apr. Review.

13.

Can we predict tuberculosis cure? What tools are available?

Goletti D, Lindestam Arlehamn CS, Scriba TJ, Anthony R, Cirillo DM, Alonzi T, Denkinger CM, Cobelens F.

Eur Respir J. 2018 Nov 8;52(5). pii: 1801089. doi: 10.1183/13993003.01089-2018. Print 2018 Nov. Review.

14.

A Novel Sensitive Immunoassay Targeting the 5-Methylthio-d-Xylofuranose-Lipoarabinomannan Epitope Meets the WHO's Performance Target for Tuberculosis Diagnosis.

Sigal GB, Pinter A, Lowary TL, Kawasaki M, Li A, Mathew A, Tsionsky M, Zheng RB, Plisova T, Shen K, Katsuragi K, Choudhary A, Honnen WJ, Nahid P, Denkinger CM, Broger T.

J Clin Microbiol. 2018 Nov 27;56(12). pii: e01338-18. doi: 10.1128/JCM.01338-18. Print 2018 Dec.

15.

Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation.

Raizada N, Khaparde SD, Rao R, Kalra A, Sarin S, Salhotra VS, Swaminathan S, Khanna A, Chopra KK, Hanif M, Singh V, Umadevi KR, Nair SA, Huddart S, Tripathi R, Surya Prakash CH, Saha BK, Denkinger CM, Boehme C.

PLoS One. 2018 Aug 30;13(8):e0202085. doi: 10.1371/journal.pone.0202085. eCollection 2018.

16.

Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Kohli M, Schiller I, Dendukuri N, Dheda K, Denkinger CM, Schumacher SG, Steingart KR.

Cochrane Database Syst Rev. 2018 Aug 27;8:CD012768. doi: 10.1002/14651858.CD012768.pub2. Review.

17.

An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease.

Kik SV, Schumacher S, Cirillo DM, Churchyard G, Boehme C, Goletti D, Rangaka MX, Denkinger CM, Lienhardt C, Gilpin C, Matteelli A, Cobelens F.

Eur Respir J. 2018 Oct 25;52(4). pii: 1800946. doi: 10.1183/13993003.00946-2018. Print 2018 Oct.

PMID:
30139776
18.

Diagnostic Test for Incipient Tuberculosis: A Step Forward, Many More to Go.

Schumacher SG, Denkinger CM.

Am J Respir Crit Care Med. 2018 May 1;197(9):1106-1107. doi: 10.1164/rccm.201803-0469ED. No abstract available.

PMID:
29624073
19.

"Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities.

McDowell A, Raizada N, Khaparde SD, Rao R, Sarin S, Kalra A, Salhotra VS, Nair SA, Boehme C, Denkinger CM.

PLoS One. 2018 Mar 16;13(3):e0193656. doi: 10.1371/journal.pone.0193656. eCollection 2018.

20.

Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India.

Raizada N, Khaparde SD, Salhotra VS, Rao R, Kalra A, Swaminathan S, Khanna A, Chopra KK, Hanif M, Singh V, Umadevi KR, Nair SA, Huddart S, Prakash CHS, Mall S, Singh P, Saha BK, Denkinger CM, Boehme C, Sarin S.

PLoS One. 2018 Feb 28;13(2):e0193194. doi: 10.1371/journal.pone.0193194. eCollection 2018.

21.

Accuracy of Xpert Mtb/Rif Ultra for the Diagnosis of Pulmonary Tuberculosis in Children.

Nicol MP, Workman L, Prins M, Bateman L, Ghebrekristos Y, Mbhele S, Denkinger CM, Zar HJ.

Pediatr Infect Dis J. 2018 Oct;37(10):e261-e263. doi: 10.1097/INF.0000000000001960.

PMID:
29474257
22.

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis.

Miotto P, Tessema B, Tagliani E, Chindelevitch L, Starks AM, Emerson C, Hanna D, Kim PS, Liwski R, Zignol M, Gilpin C, Niemann S, Denkinger CM, Fleming J, Warren RM, Crook D, Posey J, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Murray M, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, Ranganathan UDK, McNerney R, Ezewudo M, Cirillo DM, Schito M, Köser CU, Rodwell TC.

Eur Respir J. 2017 Dec 28;50(6). pii: 1701354. doi: 10.1183/13993003.01354-2017. Print 2017 Dec.

23.

Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.

Kendall EA, Schumacher SG, Denkinger CM, Dowdy DW.

PLoS Med. 2017 Dec 14;14(12):e1002472. doi: 10.1371/journal.pmed.1002472. eCollection 2017 Dec.

24.

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.

Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, Hall SL, Chakravorty S, Cirillo DM, Tukvadze N, Bablishvili N, Stevens W, Scott L, Rodrigues C, Kazi MI, Joloba M, Nakiyingi L, Nicol MP, Ghebrekristos Y, Anyango I, Murithi W, Dietze R, Lyrio Peres R, Skrahina A, Auchynka V, Chopra KK, Hanif M, Liu X, Yuan X, Boehme CC, Ellner JJ, Denkinger CM; study team.

Lancet Infect Dis. 2018 Jan;18(1):76-84. doi: 10.1016/S1473-3099(17)30691-6. Epub 2017 Nov 30. Erratum in: Lancet Infect Dis. 2018 Feb 21;:.

25.

Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses.

Lange B, Cohn J, Roberts T, Camp J, Chauffour J, Gummadi N, Ishizaki A, Nagarathnam A, Tuaillon E, van de Perre P, Pichler C, Easterbrook P, Denkinger CM.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):700. doi: 10.1186/s12879-017-2777-y. Review.

26.

Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples - a systematic review and meta-analysis.

Lange B, Roberts T, Cohn J, Greenman J, Camp J, Ishizaki A, Messac L, Tuaillon E, van de Perre P, Pichler C, Denkinger CM, Easterbrook P.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):693. doi: 10.1186/s12879-017-2776-z. Review.

27.

Detection of Mycobacterium tuberculosis pncA Mutations by the Nipro Genoscholar PZA-TB II Assay Compared to Conventional Sequencing.

Willby MJ, Wijkander M, Havumaki J, Johnson K, Werngren J, Hoffner S, Denkinger CM, Posey JE.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01871-17. doi: 10.1128/AAC.01871-17. Print 2018 Jan.

28.

Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study.

Bahr NC, Nuwagira E, Evans EE, Cresswell FV, Bystrom PV, Byamukama A, Bridge SC, Bangdiwala AS, Meya DB, Denkinger CM, Muzoora C, Boulware DR; ASTRO-CM Trial Team.

Lancet Infect Dis. 2018 Jan;18(1):68-75. doi: 10.1016/S1473-3099(17)30474-7. Epub 2017 Sep 14.

29.

Implementation of Xpert MTB/RIF in 22 high tuberculosis burden countries: are we making progress?

Cazabon D, Suresh A, Oghor C, Qin ZZ, Kik SV, Denkinger CM, Pai M.

Eur Respir J. 2017 Aug 31;50(2). pii: 1700918. doi: 10.1183/13993003.00918-2017. Print 2017 Aug. No abstract available.

30.

The New Xpert MTB/RIF Ultra: Improving Detection of Mycobacterium tuberculosis and Resistance to Rifampin in an Assay Suitable for Point-of-Care Testing.

Chakravorty S, Simmons AM, Rowneki M, Parmar H, Cao Y, Ryan J, Banada PP, Deshpande S, Shenai S, Gall A, Glass J, Krieswirth B, Schumacher SG, Nabeta P, Tukvadze N, Rodrigues C, Skrahina A, Tagliani E, Cirillo DM, Davidow A, Denkinger CM, Persing D, Kwiatkowski R, Jones M, Alland D.

MBio. 2017 Aug 29;8(4). pii: e00812-17. doi: 10.1128/mBio.00812-17.

31.

Computer-aided reading of tuberculosis chest radiography: moving the research agenda forward to inform policy.

Ahmad Khan F, Pande T, Tessema B, Song R, Benedetti A, Pai M, Lönnroth K, Denkinger CM.

Eur Respir J. 2017 Jul 13;50(1). pii: 1700953. doi: 10.1183/13993003.00953-2017. Print 2017 Jul. No abstract available.

32.

Long-lasting tuberculous pleurisy.

Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, Codecasa LR, Ottenhoff TH, Denkinger CM, Goletti D.

Eur Respir J. 2017 May 25;49(5). pii: 1700356. doi: 10.1183/13993003.00356-2017. Print 2017 May. No abstract available.

33.

Diagnostic accuracy of the Xpert® MTB/RIF cycle threshold level to predict smear positivity: a meta-analysis.

Lange B, Khan P, Kalmambetova G, Al-Darraji HA, Alland D, Antonenka U, Brown T, Balcells ME, Blakemore R, Denkinger CM, Dheda K, Hoffmann H, Kadyrov A, Lemaitre N, Miller MB, Nikolayevskyy V, Ntinginya EN, Ozkutuk N, Palacios JJ, Popowitch EB, Porcel JM, Teo J, Theron G, Kranzer K.

Int J Tuberc Lung Dis. 2017 May 1;21(5):493-502. doi: 10.5588/ijtld.16.0702. Review.

PMID:
28399963
34.

Diagnostic Performance of Tuberculosis-Specific IgG Antibody Profiles in Patients with Presumptive Tuberculosis from Two Continents.

Broger T, Basu Roy R, Filomena A, Greef CH, Rimmele S, Havumaki J, Danks D, Schneiderhan-Marra N, Gray CM, Singh M, Rosenkrands I, Andersen P, Husar GM, Joos TO, Gennaro ML, Lochhead MJ, Denkinger CM, Perkins MD.

Clin Infect Dis. 2017 Apr 1;64(7):947-955. doi: 10.1093/cid/cix023.

35.

Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study.

Havumaki J, Hillemann D, Ismail N, Omar SV, Georghiou SB, Schumacher SG, Boehme C, Denkinger CM.

PLoS One. 2017 Mar 24;12(3):e0173804. doi: 10.1371/journal.pone.0173804. eCollection 2017.

36.

Feasibility of the TBDx automated digital microscopy system for the diagnosis of pulmonary tuberculosis.

Nabeta P, Havumaki J, Ha DT, Caceres T, Hang PT, Collantes J, Thi Ngoc Lan N, Gotuzzo E, Denkinger CM.

PLoS One. 2017 Mar 2;12(3):e0173092. doi: 10.1371/journal.pone.0173092. eCollection 2017.

37.

Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence.

Lange C, Mandalakas AM, Kalsdorf B, Denkinger CM, Sester M.

Pathog Immun. 2016;1(2):308-329. doi: 10.20411/pai.v1i2.173. Epub 2016 Jan 4.

38.

A tuberculosis biomarker database: the key to novel TB diagnostics.

Yerlikaya S, Broger T, MacLean E, Pai M, Denkinger CM.

Int J Infect Dis. 2017 Mar;56:253-257. doi: 10.1016/j.ijid.2017.01.025. Epub 2017 Jan 31. Review.

39.

FIND Tuberculosis Strain Bank: a Resource for Researchers and Developers Working on Tests To Detect Mycobacterium tuberculosis and Related Drug Resistance.

Tessema B, Nabeta P, Valli E, Albertini A, Collantes J, Lan NH, Romancenco E, Tukavdze N, Denkinger CM, Dolinger DL.

J Clin Microbiol. 2017 Apr;55(4):1066-1073. doi: 10.1128/JCM.01662-16. Epub 2017 Jan 18.

40.

Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis.

Nathavitharana RR, Cudahy PG, Schumacher SG, Steingart KR, Pai M, Denkinger CM.

Eur Respir J. 2017 Jan 18;49(1). pii: 1601075. doi: 10.1183/13993003.01075-2016. Print 2017 Jan. Review.

41.

Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis.

Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, Ottenhoff TH, Denkinger CM, Goletti D.

Eur Respir J. 2016 Dec;48(6):1751-1763. doi: 10.1183/13993003.01012-2016. Epub 2016 Nov 11. Review.

42.

Tuberculosis prevention must integrate technological and basic care innovation.

Albert H, Nathavitharana RR, Denkinger CM, Isaacs C, Boehme CC.

Eur Respir J. 2016 Nov;48(5):1531-1532. doi: 10.1183/13993003.01601-2016. No abstract available.

43.

Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model.

Moses MW, Zwerling A, Cattamanchi A, Denkinger CM, Banaei N, Kik SV, Metcalfe J, Pai M, Dowdy D.

Sci Rep. 2016 Jul 29;6:30781. doi: 10.1038/srep30781.

44.

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?

Albert H, Nathavitharana RR, Isaacs C, Pai M, Denkinger CM, Boehme CC.

Eur Respir J. 2016 Aug;48(2):516-25. doi: 10.1183/13993003.00543-2016. Epub 2016 Jul 13. Review.

45.

Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis.

Freiman JM, Tran TM, Schumacher SG, White LF, Ongarello S, Cohn J, Easterbrook PJ, Linas BP, Denkinger CM.

Ann Intern Med. 2016 Sep 6;165(5):345-55. doi: 10.7326/M16-0065. Epub 2016 Jun 21. Review.

46.

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults.

Shah M, Hanrahan C, Wang ZY, Dendukuri N, Lawn SD, Denkinger CM, Steingart KR.

Cochrane Database Syst Rev. 2016 May 10;(5):CD011420. doi: 10.1002/14651858.CD011420.pub2. Review.

47.

Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance.

Nathavitharana RR, Hillemann D, Schumacher SG, Schlueter B, Ismail N, Omar SV, Sikhondze W, Havumaki J, Valli E, Boehme C, Denkinger CM.

J Clin Microbiol. 2016 Jun;54(6):1624-1630. doi: 10.1128/JCM.00251-16. Epub 2016 Apr 13.

48.

Market assessment of tuberculosis diagnostics in India in 2013.

Maheshwari P, Chauhan K, Kadam R, Pujani A, Kaur M, Chitalia M, Dabas H, Perkins MD, Boehme CC, Denkinger CM, Raizada N, Ginnard J, Jefferson C, Pantoja A, Rupert S, Kik SV, Cohen C, Chedore P, Satyanarayana S, Pai M; TB Diagnostics Market Analysis Consortium.

Int J Tuberc Lung Dis. 2016 Mar;20(3):304-13. doi: 10.5588/ijtld.15.0571.

PMID:
27046709
49.

Market assessment of tuberculosis diagnostics in China in 2012.

Zhao YL, Pang Y, Xia H, Du X, Chin D, Huan ST, Dong HY, Zhang ZY, Ginnard J, Perkins MD, Boehme CC, Jefferson C, Pantoja A, Qin ZZ, Chedore P, Denkinger CM, Pai M, Kik SV; TB Diagnostics Market Analysis Consortium.

Int J Tuberc Lung Dis. 2016 Mar;20(3):295-303. doi: 10.5588/ijtld.15.0156.

PMID:
27046708
50.

Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies.

Schumacher SG, Sohn H, Qin ZZ, Gore G, Davis JL, Denkinger CM, Pai M.

PLoS One. 2016 Mar 8;11(3):e0151073. doi: 10.1371/journal.pone.0151073. eCollection 2016. Review.

Supplemental Content

Loading ...
Support Center